Suven Life Scie.

{
  "main_header": {
    "sid": 588414,
    "name": "Suven Life Scie.",
    "stock_name": "Suven Life Scie.",
    "full_name": "Suven Life Sciences Ltd",
    "name_url": "stocks-analysis/suven-life-scie",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "157.40",
    "chg": 9.9,
    "chgp": "6.71%",
    "dir": 1,
    "prev_price": "147.50",
    "mcapval": "3,804.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 530239,
    "symbol": "SUVEN",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE495B01038",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "11.45 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/suven-life-scie-588414-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Suven Life Sciences Ltd Surges 7.25% to Day's High of Rs 159 — Outperforms Sector by 9.45 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-hits-intraday-high-with-725-surge-on-2-april-2026-3930524",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SuvenLifeScienc_priceRelatedfactors_3930524.png",
        "date": "2026-04-02 13:15:56",
        "description": "The Sensex declined sharply by 1.44% on 2 Apr 2026, yet Suven Life Sciences Ltd surged 7.25%, reaching an intraday high of Rs 159. This 9.45-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-driven move."
      },
      {
        "title": "Suven Life Sciences Ltd Surges 7.79% to Day's High of Rs 144.7 — Outperforms Sector by 5.72 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-hits-intraday-high-with-779-surge-on-1-april-2026-3928775",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SuvenLifeScienc_priceRelatedfactors_3928775.png",
        "date": "2026-04-01 10:22:51",
        "description": "The Sensex advanced 2.49% on 1 Apr 2026, yet Suven Life Sciences Ltd outpaced the broader market with a 7.79% gain, reaching an intraday high of Rs 144.7. This 5.72-percentage-point outperformance over the Pharmaceuticals & Drugs sector's 2.07% rise highlights a distinctly stock-specific rally rather than a mere market tailwind."
      },
      {
        "title": "Suven Life Sciences Ltd Surges 7.88% to Day's High of Rs 141 — Outperforms Sector by 8.06 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-hits-intraday-high-with-788-surge-on-30-mar-2026-3924009",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SuvenLifeScienc_priceRelatedfactors_3924009.png",
        "date": "2026-03-30 09:46:39",
        "description": "The Sensex declined by 0.83% on 30 Mar 2026, while Suven Life Sciences Ltd surged 7.88%, outperforming its Healthcare Services sector by over 8 percentage points. This sharp single-session gain stands out amid a broadly weak market, signalling a stock-specific event rather than a general market uplift."
      },
      {
        "title": "Suven Life Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-ltd-is-rated-strong-sell-3922764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SuvenLifeScienc_mojoScore_3922764.png",
        "date": "2026-03-29 10:10:14",
        "description": "Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Suven Life Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-ltd-is-rated-strong-sell-3898487",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SuvenLifeScienc_mojoScore_3898487.png",
        "date": "2026-03-18 10:10:27",
        "description": "Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Suven Life Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-ltd-is-rated-strong-sell-3877905",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SuvenLifeScienc_mojoScore_3877905.png",
        "date": "2026-03-07 10:10:15",
        "description": "Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 March 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Suven Life Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-faces-bearish-momentum-amid-technical-downgrade-3859522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SuvenLifeScienc_technicaldot_3859522.png",
        "date": "2026-02-27 08:01:32",
        "description": "Suven Life Sciences Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with multiple indicators signalling a bearish trend. The company’s MarketsMOJO grade has been downgraded from Sell to Strong Sell as of 6 August 2025, reflecting growing concerns over its near-term price trajectory despite its strong long-term returns relative to the Sensex."
      },
      {
        "title": "Suven Life Sciences Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/suven-life-sciences-ltd-sees-mixed-technical-signals-amid-mildly-bearish-momentum-3857281",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SuvenLifeScienc_technicaldot_3857281.png",
        "date": "2026-02-26 08:01:23",
        "description": "Suven Life Sciences Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.97%, the stock’s broader trend signals and momentum oscillators suggest cautious investor sentiment amid mixed signals from key technical parameters."
      },
      {
        "title": "Suven Life Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/suven-life-sciences-ltd-is-rated-strong-sell-3852671",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SuvenLifeScienc_mojoScore_3852671.png",
        "date": "2026-02-24 10:10:27",
        "description": "Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 5259,
    "sid": "588414",
    "stock_news_url": "https://www.marketsmojo.com/news/suven-life-sciences-588414"
  },
  "announcements": [
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "Closure of Trading window",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "09-Mar-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Jasti Property & Equity Holdings Pvt Ltd & PACs",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for ALLOTMENT OF 31768764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASIS",
      "datetime": "06-Mar-2026",
      "details": "ALLOTMENT OF 31768764 EQUITY SHARES OF THE COMPANY ON PREFERENTIAL BASIS",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has declared <strong>150%</strong> dividend, ex-date: 14 Feb 19",
          "dt": "2019-02-14",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:2</strong> stock split, ex-date: 23 Mar 07",
          "dt": "2007-03-23",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Mar 07",
          "dt": "2007-03-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Suven Life Sciences Ltd has announced <strong>1:2</strong> rights issue, ex-date: 17 Oct 22",
          "dt": "2022-10-17",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Suven Life Sciences Ltd Surges 7.25% to Day's High of Rs 159 — Outperforms Sector by 9.45 Percentage Points

2026-04-02 13:15:56

The Sensex declined sharply by 1.44% on 2 Apr 2026, yet Suven Life Sciences Ltd surged 7.25%, reaching an intraday high of Rs 159. This 9.45-percentage-point outperformance over its Healthcare Services sector peers signals a distinctly stock-specific rally rather than a market-driven move.

Read full news article

Suven Life Sciences Ltd Surges 7.79% to Day's High of Rs 144.7 — Outperforms Sector by 5.72 Percentage Points

2026-04-01 10:22:51

The Sensex advanced 2.49% on 1 Apr 2026, yet Suven Life Sciences Ltd outpaced the broader market with a 7.79% gain, reaching an intraday high of Rs 144.7. This 5.72-percentage-point outperformance over the Pharmaceuticals & Drugs sector's 2.07% rise highlights a distinctly stock-specific rally rather than a mere market tailwind.

Read full news article

Suven Life Sciences Ltd Surges 7.88% to Day's High of Rs 141 — Outperforms Sector by 8.06 Percentage Points

2026-03-30 09:46:39

The Sensex declined by 0.83% on 30 Mar 2026, while Suven Life Sciences Ltd surged 7.88%, outperforming its Healthcare Services sector by over 8 percentage points. This sharp single-session gain stands out amid a broadly weak market, signalling a stock-specific event rather than a general market uplift.

Read full news article

Suven Life Sciences Ltd is Rated Strong Sell

2026-03-29 10:10:14

Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Suven Life Sciences Ltd is Rated Strong Sell

2026-03-18 10:10:27

Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 August 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 18 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Suven Life Sciences Ltd is Rated Strong Sell

2026-03-07 10:10:15

Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 August 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 March 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Suven Life Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-02-27 08:01:32

Suven Life Sciences Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with multiple indicators signalling a bearish trend. The company’s MarketsMOJO grade has been downgraded from Sell to Strong Sell as of 6 August 2025, reflecting growing concerns over its near-term price trajectory despite its strong long-term returns relative to the Sensex.

Read full news article

Suven Life Sciences Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum

2026-02-26 08:01:23

Suven Life Sciences Ltd has exhibited a nuanced shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a modest day gain of 0.97%, the stock’s broader trend signals and momentum oscillators suggest cautious investor sentiment amid mixed signals from key technical parameters.

Read full news article

Suven Life Sciences Ltd is Rated Strong Sell

2026-02-24 10:10:27

Suven Life Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 August 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 February 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

View All News